Anyone following the news knows by now that it’s been a good few days for covid-19 vaccines. None of the phase III results have been peer-reviewed. Typically phase III trials run for anywhere from one to four years. In the coming days, other companies will present their own interim phase III results. By the end of 2020, Moderna expects it will have 20 million vaccine doses.

Source: Mint November 17, 2020 14:37 UTC